All anti-CD20 monoclonal antibodies have similar efficacy and risks: Commentary
Ian Dimaandal1, Jaime Imitola1
1UConn Health Comprehensive MS Center, Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, USA.
Abstract
No abstract available in PubMed .


![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)